Steady-state pharmacokinetics of oestradiol gel in post-menopausal women: Effects of application area and washing

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 104, Issue , 1997, Pages 14-18

  Jarvinen A ^a   Granander, M ^b   Nykanen S ^b   Laine, T ^b   Geurts, P ^c   Viitanen, A ^b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b ORION CORPORATION   (Finland)

^c NV ORGANON   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; UNCLASSIFIED DRUG;

ADULT; AGED; AREA UNDER THE CURVE; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; ESTROGEN DEFICIENCY; FEMALE; HUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TRANSDERMAL DRUG ADMINISTRATION;

ADMINISTRATION, CUTANEOUS; AGED; BIOLOGICAL AVAILABILITY; CROSS-OVER STUDIES; ESTRADIOL; FEMALE; GELS; HUMANS; HYGIENE; MIDDLE AGED; POSTMENOPAUSE; SKIN ABSORPTION;

EID: 0030777934     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1997.tb11562.x     Document Type: Article

References (18)

1. Chetkowski RJ. Meldrum DR. Sleingold KA et al. Biologic effects of transdermal estradiol. N Engl J Med 1986; 314: 1615–1620.
2. Laufer LR, DeFazio JL, Lu JKH et al. Estrogen replacement therapy by transdermal estradiol administration. Am J Obstet Gynecol 1983: 146: 533–540.
3. Holst J, Cajander S. Carlström K, Damber M-G, Schoultz B von. A comparison of liver protein induction in postmenopausal women during oral and percutaneous oestrogen replacement therapy. Br J Obstet Gynaecol 1983; 90: 355–360.
4. Scott RT, Ross B, Anderson C, Archer DF. Pharmacokinetics of percutaneous estradiol: A cross-over study using a gel and a transdermal system in comparison with oral micronized estradiol. Obstet Gynecol 1991; 77: 758–764.
5. Powers MS, Schenkel L. Darley PE, Good WR, Balestra JC, Place VA. Pharmacokinetics and pharmacodynamics of transdermal doseage forms of 17β-estradiol: Comparison with conventional oral estrogens used for hormone replacement. Am J Obstet Gynecol 1985: 152: 1099–1106.
6. Geola FL, Frumar AM, Tataryn IV et al. Biological effects (dose-response) of conjugated equine estrogens in postmenopausal women. J Clin Endocrinol Metab 1980; 51: 620–625.
7. Selby PL, McGarrigle HHG, Peacock M. Comparison of the effects of oral and transdermal oestradiol administration on oestrogen metabolism, protein synthesis, gonadotrohin release, bone turnover and climacteric symptoms in postmenopausal women. Clin Endocrinol 1989; 30: 241–249.
8. Padwick ML, Endacott J, Whitehead MI. Efficacy, acceptability, and metabolic effects of transdermal estradiol in the management of postmenopausal women. Am J Obstet Gynecol 1985; 152: 1085–1091.
9. Place VA, Powers M, Darley PE, Schenkel L, Good WR. A double-blind comparative study of Estraderm and Premarin in the amelioration of post-menopausal symptoms. Am J Obstet Gynecol 1985; 152: 1092–1099.
10. Cheang A, Sitruk-Ware R, Utian WH. A risk-benefit appraisal of transdermal estradiol therapy. Drug Safety 1993; 9: 365–379.
11. Rozenbaum H, Birkhäuser M, Nooyer C de, Lambotte R. Pornel B. Schneider H, Studd J. Comparison of two estradiol transdermal systems (Oesclim, 50 and Estraderm ITS, 50). 1. Tolerability, adhesion and efficacy. Maturitas 1996; 25: 161–173.
12. Rozenbaum H, Birkhäuser M, Nooyer C de et al. Comparison of two estradiol transdermal systems (Oesclim, 50 and Estraderm TTS, 50). II. Local skin tolerability. Maturitas 1996; 25: 175–185.
13. Chanez JF, Lignieres B de, Marty JP, Wepierre J. Influence of the size of the area of treatment on percutaneous absorption of estradiol in the rat. Skin Pharmacol 1989; 2: 15–21.
14. Simon JA, Hodgen GD, Archer D.F. Are there significant differences between patch and gel cutaneous estradiol therapy? In Recent Research on Gynecological Endocrinology. Genazzani AR, Petraglia F, Volpe A, eds. Parthenon Publishing, Casterton Hall. 1988: 317–324.
15. Scheuplein RJ, Blank JH. Permeability of skin. Physiol Rev 1971; 51: 702–742.
16. Feldmann RJ. Maibach R. Penetration of 14C hydrocortisone through normal skin. Arch Dermatol 1965; 91: 661–666.
17. Feldmann RJ, Maibach HI. Percutaneous penetration of steroids in man. J Invest Dermatol 1969; 52: 89–94.
18. Simon JA, Leal J, Hodgen GD. Percutaneous absorption of 17β-estradiol in ovariectomized rhesus monkeys: Skin and serum pharmacokinetics. Fertil Steril 1990; 53: 561–565.